MTVA Stock Analysis: Buy, Sell, or Hold?
MTVA - MetaVia Inc. Common Stock
$1.09
-0.24 (-18.05%)
▼
5d:
-24.31%
30d:
-8.4%
90d:
-40.11%
WAIT
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 13, 2026
3d
Get Alerted When MTVA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MTVA is down 24.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MTVA is down 24.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MTVA is currently trading at $1.09, which is considered oversold relative to its 30-day fair value range of $1.25 to $1.54.
Technical Outlook: Technically, MTVA is in a strong downtrend. Immediate support is located at $1.00, while resistance sits at $1.67. Short-term momentum is weak, with the stock down 18.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.33 (+1673.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MTVA is in a strong downtrend. Immediate support is located at $1.00, while resistance sits at $1.67. Short-term momentum is weak, with the stock down 18.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19.33 (+1673.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.25 -
$1.54
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-18.0%)
- BULLISH: Trading 1673.7% below Wall St target ($19.33)
- WARNING: Recommendation downgraded due to -24.3% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.25 -
$1.54
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.00
Resistance Level
$1.67
Current Trend
Strong Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.46
Wall Street Target
$19.33
(+1673.7%)
Share & Embed Analysis
Last updated: May 09, 2026 11:19 AM ET
Data refreshes hourly during market hours. Next update: 12:19 PM
Data refreshes hourly during market hours. Next update: 12:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MTVA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$408 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 58 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$27 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 56 HOLD |
